다낭성난소증후군의 인슐린 저항성 치료에 대한 한약 기전 및 빈용 본초 : 동물연구에 대한 체계적 문헌 고찰

키워드

참고문헌 (68)

1. Teede HJ, "Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome", J Clin Endocrinol Metab, 108(10), pp.2447~2469 (2023)
2. Escobar-Morreale HF, "Polycystic ovary syndrome : definition, aetiology, diagnosis and treatment", Nat Rev Endocrinol, 14(5), pp.270~284 (2018)
3. Christ JP, "Current Guidelines for Diagnosing PCOS", Diagnostics(Basel), 13(6), pp.1113~ (2023)
4. Zhao H, "Comparative efficacy of oral insulin sensitizers metformin, thiazolidinediones, inositol, and berberine in improving endocrine and metabolic profiles in women with PCOS : a network meta-analysis", Reprod Health, 18(1), pp.171~ (2021)
5. Kruszewska J, "Review of Novel Potential Insulin Resistance Biomarkers in PCOS Patients-The Debate Is Still Open", Int J Environ Res Public Health, 19(4), pp.2099~ (2022)
6. Rosenfield RL, "The Pathogenesis of Polycystic Ovary Syndrome(PCOS) : The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited", Endocr Rev, 37(5), pp.467~520 (2016)
7. Sirmans SM, "Epidemiology, diagnosis, and management of polycystic ovary syndrome", Clin Epidemiol, 6, pp.1~13 (2013)
8. Seli E, "Should patients with polycystic ovarian syndrome be treated with metformin?", Human Reproduction, 17(9), pp.2230~2236 (2002)
9. Dumitrescu R, "Metformin-Clinical Pharmacology in PCOs", J Med Life, 8(2), pp.187~192 (2015)
10. Lord JM, "Metformin in polycystic ovary syndrome : systematic review and meta-analysis", BMJ, 327(7421), pp.951~953 (2003)
11. Dixon SA, "The effects of prebiotics on gastrointestinal side effects of metformin in youth : A pilot randomized control trial in youth-onset type 2diabetes", Front Endocrinol(Lausanne), 14, pp.1125187~ (2023)[DOI]
12. Chen H, "Effects of TCM on polycystic ovary syndrome and its cellular endocrine mechanism", Front Endocrinol(Lausanne), 14, pp.956772~ (2023)[DOI]
13. Korean medicine obstetrics & gynecology textbook compilation committee, "Korean medicine obstetrics & gynecology(Ⅱ)", pp.225~237 (2016), Euiseongdang
14. Ong M, "Chinese Herbal Medicine for the Optimal Management of Polycystic Ovary Syndrome", Am J Chin Med, 45(3), pp.405~422 (2017)
15. Shen W, "The Effects of Traditional Chinese Medicine-Associated Comple mentary and Alternative Medicine on Women with Polycystic Ovary Syndrome", Evid Based Complement Alternat Med, 2021, pp.6619597~ (2021)[DOI]
16. Qian H, "Efficacy of Bushen Huatan Decoction combined with Baduanjin in the treatment of polycystic ovary syndrome with insulin resistance(IR-PCOS), kidney deficiency and phlegm dampness : study protocol for a randomized controlled trial", Trials, 22(1), pp.781~ (2021)
17. Shi N, "A network pharmacology study of mechanism and efficacy of Jiawei Huanglian-Wendan decoction in polycystic ovary syndrome with insulin resistance", Medicine, 101(48), pp.e32057~ (2022)[DOI]
18. Kwon CY, "Therapeutic Effects and Mechanisms of Herbal Medicines for Treating Polycystic Ovary Syndrome : A Review", Front Pharmacol, 11, pp.1192~ (2020)[DOI]
19. Jung W, "Effects of natural products on polycystic ovary syndrome : From traditional medicine to modern drug discovery", Heliyon, 9(10), pp.e20889~ (2023)[DOI]
20. Ashkar F, "The Role of medicinal herbs in treatment of insulin resistance in patients with Polycystic Ovary Syndrome : A literature review", Biomol Concepts, 11(1), pp.57~75 (2020)
21. Huang D, "Effects of bushen tongmai recipe on expression of phosphatidylinositol-3-kinase in PCOS rats accompanying with insulin resistance", Zhongguo Zhong Yao Za Zhi, 35(13), pp.1735~1739 (2010)
22. Liang C, "Controlling effect of bushen huatan compound on the insulin signal conducting molecule inside ovaries in polycystic ovary syndrome model rats", Zhongguo Zhong Xi Yi Jie He Za Zhi, 31(12), pp.1639~1644 (2011)
23. Hong YL, "Effect of Bushen Huatan Recipe on the Akt signal pathway in polycystic ovarian syndrome model rats with insulin resistance : an experimental research", Zhongguo Zhong Xi Yi Jie He Za Zhi, 34(2), pp.230~234 (2014)
24. Wang LH, "Potent therapeutic effects of shouwu jiangqi decoction on polycystic ovary syndrome with insulin resistance in rats", Chin J Integr Med, 22(2), pp.116~123 (2016)
25. Qiu Z, "Liuwei Dihuang Pills alleviate the polycystic ovary syndrome with improved insulin sensitivity through PI3K", Akt signaling pathway, 2020, pp.250, 111965~
26. Wang C, "Cangfudaotan Decoction Alleviates Insulin Resistance and Improves Follicular Development in Rats with Polycystic Ovary Syndrome via IGF-1-PI3K", Akt-Bax, Mediators Inflamm, pp.2020, 2020[DOI]
27. Zhu Y, "Guizhi Fuling Wan, Chinese Herbal Medicine, Ameliorates Insulin Sensitivity in PCOS Model Rats With Insulin Resistance via Remodeling Intestinal Homeostasis", Front Endocrinol(Lausanne), 11, pp.575~ (2020)[DOI]
28. Lian Y, "Use of Bao Gui capsule in treatment of a polycystic ovary syndrome rat model", Mol Med Rep, 21(3), pp.1461~1470 (2020)
29. Xu Y, "Traditional Chinese Medicine formula FTZ protects against polycystic ovary syndrome through modulating adiponectin-mediated fat-ovary crosstalk in mice", J Ethnopharmacol, 268, pp.113587~ (2021)[DOI]
30. Liu S, "Modified Cangfu Daotan decoction ameliorates polycystic ovary syndrome with insulin resistance via NF-κB", LCN-2 signaling pathway in inflammatory microenvironment, 2022, pp.13, 975724~
31. Zhang Q, "Chinese herbal medicine alleviates the pathogenesis of polycystic ovary syndrome by improving oxidative stress and glucose metabolism via mitochondrial Sirtuin 3 signaling", Phytomedicine, 109, pp.154556~ (2023)[DOI]
32. Zhao H, "Modified Banxia Xiexin Decoction Ameliorates Polycystic Ovarian Syndrome With Insulin Resistance by Regulating Intestinal Microbiota", Front Cell Infect Microbiol, 12, pp.854796~ (2022)[DOI]
33. Tian J, "Metabolomics combined with network pharmacology to explore the mechanisms of modified Guishen pill to ameliorate polycystic ovary syndrome", Comput Biol Med, 148, pp.105790~ (2022)
34. Wang Y, "Effects of Bu Shen Hua Zhuo formula on the LPS", TLR4pathway and gut microbiota in rats with letrozole-induced polycystic ovary syndrome, 2022, pp.13, 891297~
35. Wu YY, "Network pharmacology integrated with experimental validation reveals the regulatory mechanism of action of Hehuan Yin decoction in polycystic ovary syndrome with insulin resistance", J Ethnopharmacol, 289, pp.115057~ (2022)[DOI]
36. Kuscu NK, "Insulin and oral antidiabetic agents for treatment of polycystic ovary syndrome", Medscape Womens Health, 7(5), pp.3~ (2002)
37. Al-Ruthia YS, "Ovulation induction by metformin among obese versus non-obese women with polycystic ovary syndrome", Saudi Pharm J, 25(5), pp.795~800 (2017)
38. Rashid R, "Polycystic ovarian syndrome-current pharmacotherapy and clinical implications", Taiwanese Journal of Obstetrics and Gynecology, 61(1), pp.40~50 (2022)
39. Mu J, "microRNA-103 Contributes to Progression of Polycystic Ovary Syndrome Through Modulating the IRS1", PI3K, Arch Med Res, pp.2021, 52(5)[DOI]
40. Guo S, "Insulin Signaling, Resistance, and the Metabolic Syndrome : Insights from Mouse Models to Disease Mechanisms", J Endocrinol, 220(2), pp.T1~ (2014)
41. Hançer NJ, "Insulin and Metabolic Stress Stimulate Multisite Serine", Threonine Phosphorylation of Insulin Receptor Substrate 1 and Inhibit Tyrosine Phosphorylation, 2014, pp.289(18), 12467~12484
42. Tong C, "Insulin resistance, autophagy and apoptosis in patients with polycystic ovary syndrome : Association with PI3K signaling pathway", Front Endocrinol(Lausanne), 13, pp.1091147~ (2022)[DOI]
43. Kumariya S, "Autophagy in ovary and polycystic ovary syndrome : role, dispute and future perspective", Autophagy, 17(10), pp.2706~2733 (2021)
44. Zhang Q, "Hydroxy-α-sanshool isolated from Zanthoxylum bungeanum Maxim. has antidiabetic effects on high-fat-fed and streptozotocin-treated mice via increasing glycogen synthesis by regulation of PI3K", Akt, GS signaling, pp.Front Pharmacol, 2022[DOI]
45. Le Marchand-Brustel Y, "Fatty acid-induced insulin resistance : role of insulin receptor substrate 1 serine phosphorylation in the retroregulation of insulin signalling", Biochemical Society Transactions, 31(6), pp.1152~1156 (2003)
46. Cui Y, "κ-Opioid receptor stimulation reduces palmitate-induced apoptosis via Akt", eNOS signaling pathway, 2019, pp.18(1), 52~
47. Kashiwagi S, "eNOS phosphorylation on serine 1176 affects insulin sensitivity and adiposity", Biochem Biophys Res Commun, 431(2), pp.284~290 (2013)
48. Sun Y, "Gut microbiota dysbiosis in polycystic ovary syndrome : Mechanisms of progression and clinical applications", Front Cell Infect Microbiol, 13, pp.1142041~ (2023)[DOI]
49. Sivasankari R, "Reshaping the Gut Microbiota Through Lifestyle Interventions in Women with PCOS : A Review", Indian J Microbiol, 62(3), pp.351~363 (2022)
50. Shen W, "The Effects of Salvia miltiorrhiza on Reproduction and Metabolism in Women with Polycystic Ovary Syndrome : A Systematic Review and Meta-Analysis", Evid Based Complement Alternat Med, 2021, pp.9971403~ (2021)[DOI]
51. Huang Y, "Cryptotanshinone reverses ovarian insulin resistance in mice through activation of insulin signaling and the regulation of glucose transporters and hormone synthesizing enzymes", Fertility and Sterility, 102(2), pp.589~596 (2014)
52. Nie A, "Phytochemistry and Pharmacological Activities of Wolfiporia cocos (F.A. Wolf) Ryvarden & Gilb", Front Pharmacol, 11, pp.505249~ (2020)[DOI]
53. Zhu L, "Regulation of gut microbiota and intestinal metabolites by Poria cocos oligosaccharides improves glycolipid metabolism disturbance in high-fat diet-fed mice", The Journal of Nutritional Biochemistry, 107, pp.109019~ (2022)[DOI]
54. Li TH, "Anti-Hyperglycemic Properties of Crude Extract and Triterpenes from Poria cocos", Evid Based Complement Alternat Med, 2011, pp.128402~ (2011)[DOI]
55. Guo Y, "The effect of total flavonoids of Epimedium on granulosa cell development in laying hens", Poult Sci, 99(9), pp.4598~4606 (2020)
56. Cao LH, "PI3K-AKT Signaling Activation and Icariin : The Potential Effects on the Perimenopausal Depression-Like Rat Model", Molecules, 24(20), pp.3700~ (2019)[DOI]
57. Xue BX, "Phytochemistry, data mining, pharmacology, toxicology and the analytical methods of Cyperus rotundus L. (Cyperaceae) : a comprehensive review", Phytochem Rev, 22, pp.1353~1398 (2023)
58. Zhang J, "Astragaloside IV derived from Astragalus membranaceus : A research review on the pharmacological effects", Advances in Pharmacology, 87, pp.89~112 (2020)
59. Li R, "Astragalus polysaccharide alleviates polycystic ovary syndrome by reducing insulin resistance and oxidative stress and increasing the diversity of gut microbiota", Endocrine, 83(3), pp.783~797 (2024)
60. Zou T, "A review of the research progress on Pinellia ternata (Thunb.)Breit.: Botany, traditional uses, phytochemistry, pharmacology, toxicity and quality control", Heliyon, 9(11), pp.e22153~ (2023)[DOI]
61. Lu HK, "Pinellia ternata attenuates carotid artery intimal hyperplasia and increases endothelial progenitor cell activity via the PI3K", Akt signalling pathway in wire-injured rats, 2020, pp.58(1), 1193~1200
62. Gao Y, "The efficacy and mechanism of Angelica sinensis (Oliv.) Diels root aqueous extract based on RNA sequencing and 16S rDNA sequencing in alleviating polycystic ovary syndrome", Phytomedicine, 120, pp.155013~ (2023)[DOI]
63. Wang K, "Angelica sinensis polysaccharide regulates glucose and lipid metabolism disorder in prediabetic and streptozotocin-induced diabetic mice through the elevation of glycogen levels and reduction of inflammatory factors", Food Funct, 6(3), pp.902~909 (2015)
64. Sun L, "Additional Benefit of Chinese Medicine Formulae Including Dioscoreae rhizome(Shanyao)for Diabetes Mellitus : Current State of Evidence", Front Endocrinol(Lausanne), 11, pp.553288~ (2020)[DOI]
65. Lok Wong K, "A Novel, Stable, Estradiol-Stimulating, Osteogenic Yam Protein with Potential for the Treatment of Menopausal Syndrome", Sci Rep, 5, pp.10179~ (2015)[DOI]
66. Zhang WJ, "Atractylodis Rhizoma : A review of its traditional uses, phytochemistry, pharmacology, toxicology and quality control", J Ethnopharmacol, 266, pp.113415~ (2021)[DOI]
67. Han HK, "Effects of Atractylodes lancea on Plasma Glucose and Lipid Profile in Streptozotocin Induced Diabetic Rats", The Korean Journal of Food And Nutrition, 33(5), pp.544~550 (2020)
68. Park SY, "A Study on the Clinical Study of Herbal Medicine for Glucose-Lipid Metabolism Abnormalities in Polycystic Ovary Syndrome", The Journal of Oriental Gynecology, 32(4), pp.67~86 (2019)

관련 논문AI추천